Your browser doesn't support javascript.
loading
Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients.
Vignon, M; Javaugue, V; Alexander, M P; El-Karoui, K; Karras, A; Roos-Weil, D; Royer, B; Asli, B; Knebelmann, B; Touchard, G; Jaccard, A; Arnulf, B; Bridoux, F; Leung, N; Fermand, J P.
Affiliation
  • Vignon M; Department of Hematology and Clinical Immunology, INSERM UMR 1126 Institut Universitaire d'Hématologie, Saint Louis University Hospital, Paris, France.
  • Javaugue V; Department of Nephrology, Dialysis and Renal Transplantation, Centre de référence amylose AL et autres maladies par dépôts d'immunoglobuline monoclonales, University Hospital of Poitiers, Poitiers, France.
  • Alexander MP; Department of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
  • El-Karoui K; Department of Nephrology, Necker University Hospital, Paris, France.
  • Karras A; Department of Nephrology, Georges Pompidou University Hospital, Paris, France.
  • Roos-Weil D; Department of Hematology, Pitié-Salpétrière University Hospital, Paris, France.
  • Royer B; Department of Hematology, University Hospital of Amiens, Amiens, France.
  • Asli B; Department of Hematology and Clinical Immunology, INSERM UMR 1126 Institut Universitaire d'Hématologie, Saint Louis University Hospital, Paris, France.
  • Knebelmann B; Department of Nephrology, Necker University Hospital, Paris, France.
  • Touchard G; Departments of Nephrology and Ultrastructural Pathology, Centre national de référence amylose AL et autres maladies par dépôts d'immunoglobulines monoclonales, University Hospital of Poitiers, Poitiers, France.
  • Jaccard A; Department of Hematology, Centre national de référence amylose AL et autres maladies par dépots d'immunoglobulines monoclonales, University Hospital of Limoges, Limoges, France.
  • Arnulf B; Department of Immunology, National Center for Scientific Research, Joint Research Unit 7276, University of Limoges, Centre de référence de l'amylose AL et des autres maladies par dépôts d'immunoglobuline monoclonale, Limoges, France.
  • Bridoux F; Department of Hematology and Clinical Immunology, INSERM UMR 1126 Institut Universitaire d'Hématologie, Saint Louis University Hospital, Paris, France.
  • Leung N; Department of Nephrology, Dialysis and Renal Transplantation, Centre de référence amylose AL et autres maladies par dépôts d'immunoglobuline monoclonales, University Hospital of Poitiers, Poitiers, France.
  • Fermand JP; Department of Immunology, National Center for Scientific Research, Joint Research Unit 7276, University of Limoges, Centre de référence de l'amylose AL et des autres maladies par dépôts d'immunoglobuline monoclonale, Limoges, France.
Leukemia ; 31(1): 123-129, 2017 01.
Article in En | MEDLINE | ID: mdl-27435002

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light Chains / Fanconi Syndrome Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light Chains / Fanconi Syndrome Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: France